These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 16521635

  • 41. Transpulmonary B-type natriuretic peptide uptake and cyclic guanosine monophosphate release in heart failure and pulmonary hypertension: the effects of sildenafil.
    Melenovsky V, Al-Hiti H, Kazdova L, Jabor A, Syrovatka P, Malek I, Kettner J, Kautzner J.
    J Am Coll Cardiol; 2009 Aug 11; 54(7):595-600. PubMed ID: 19660688
    [Abstract] [Full Text] [Related]

  • 42. Sildenafil therapy for pulmonary arterial hypertension associated with atrial septal defects.
    Lim ZS, Salmon AP, Vettukattil JJ, Veldtman GR.
    Int J Cardiol; 2007 May 31; 118(2):178-82. PubMed ID: 17027100
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Acute hemodynamic response to vasodilators in primary pulmonary hypertension.
    Kulkarni H, Srinivas A, Vora A, Kerkar P, Dalvi B.
    J Postgrad Med; 1996 May 31; 42(1):7-11. PubMed ID: 9715289
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Biological serum markers in the management of pediatric pulmonary arterial hypertension.
    Van Albada ME, Loot FG, Fokkema R, Roofthooft MT, Berger RM.
    Pediatr Res; 2008 Mar 31; 63(3):321-7. PubMed ID: 18287971
    [Abstract] [Full Text] [Related]

  • 47. Unpredictable response to vasodilator therapy in primary pulmonary hypertension.
    Schmiedt MI, Shettigar UR, Siddique M, Barbier G, Bialow M, Carranza S.
    Int J Clin Pharmacol Ther; 1998 Aug 31; 36(8):435-40. PubMed ID: 9726697
    [Abstract] [Full Text] [Related]

  • 48. A prospective, randomized, crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients.
    Khan TA, Schnickel G, Ross D, Bastani S, Laks H, Esmailian F, Marelli D, Beygui R, Shemin R, Watson L, Vartapetian I, Ardehali A.
    J Thorac Cardiovasc Surg; 2009 Dec 31; 138(6):1417-24. PubMed ID: 19931670
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Inhaled nitric oxide versus aerosolized iloprost for the treatment of pulmonary hypertension with left heart disease.
    Yin N, Kaestle S, Yin J, Hentschel T, Pries AR, Kuppe H, Kuebler WM.
    Crit Care Med; 2009 Mar 31; 37(3):980-6. PubMed ID: 19237907
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Comparison of hemodynamic parameters in treatment-naïve and pre-treated patients with pulmonary arterial hypertension in the randomized phase III PATENT-1 study.
    Galiè N, Grimminger F, Grünig E, Hoeper MM, Humbert M, Jing ZC, Keogh AM, Langleben D, Rubin LJ, Fritsch A, Davie N, Ghofrani HA.
    J Heart Lung Transplant; 2017 May 31; 36(5):509-519. PubMed ID: 28190787
    [Abstract] [Full Text] [Related]

  • 53. The acute administration of vasodilators in primary pulmonary hypertension. Experience from the National Institutes of Health Registry on Primary Pulmonary Hypertension.
    Weir EK, Rubin LJ, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Elliott CG, Fishman AP, Goldring RM, Groves BM.
    Am Rev Respir Dis; 1989 Dec 31; 140(6):1623-30. PubMed ID: 2690706
    [Abstract] [Full Text] [Related]

  • 54. The efficacy and safety of sildenafil in Chinese patients with pulmonary arterial hypertension.
    Xu XQ, Jing ZC, Zhang JH, Wu Y, Wang Y, Jiang X, Wang ZX, Sun YG, Pu JL, Yang YJ.
    Hypertens Res; 2009 Oct 31; 32(10):911-5. PubMed ID: 19644505
    [Abstract] [Full Text] [Related]

  • 55. [Clinical interpretation for the pressure-flow relationships in extrinsic allergic alveolitis and in interstitial lung disease pulmonary hypertension patients. Should we care for the lung, the pulmonary artery pressure or both?].
    Lupi-Herrera E, Santos-Martínez LE, Pulido T, Sandoval J.
    Arch Cardiol Mex; 2009 Oct 31; 79(2):91-103. PubMed ID: 19722378
    [Abstract] [Full Text] [Related]

  • 56. Aerosolized iloprost for primary pulmonary hypertension.
    Ewert R, Wensel R, Opitz CF.
    N Engl J Med; 2000 Nov 09; 343(19):1421-2. PubMed ID: 11183891
    [No Abstract] [Full Text] [Related]

  • 57. Effects of chronic sildenafil in patients with Eisenmenger syndrome versus idiopathic pulmonary arterial hypertension.
    Chau EM, Fan KY, Chow WH.
    Int J Cardiol; 2007 Sep 03; 120(3):301-5. PubMed ID: 17174418
    [Abstract] [Full Text] [Related]

  • 58. [Impact of pulmonary hypertension on early hemodynamics after orthotopic heart transplantation].
    Liu MZ, Wang JH, Du J, Huang J, Li LH.
    Zhonghua Yi Xue Za Zhi; 2007 Oct 09; 87(37):2618-22. PubMed ID: 18162149
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Markers of pulmonary hypertension in potential candidates to heart transplantation.
    Wierzbicki K, Przybyłowski P, Sobczyk D, Konstanty J, Kapelak B, Drwiła R, Krochin M, Podolec P, Wójcik S, Marek G, Wróbel K, Piatek J, Rudziński P, Sadowski J.
    Przegl Lek; 2006 Oct 09; 63(12):1263-8. PubMed ID: 17642136
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.